Avecho Biotechnology Balance Sheet Health
Financial Health criteria checks 6/6
Avecho Biotechnology has a total shareholder equity of A$6.4M and total debt of A$0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are A$7.3M and A$941.5K respectively.
Key information
0%
Debt to equity ratio
AU$0
Debt
Interest coverage ratio | n/a |
Cash | AU$5.50m |
Equity | AU$6.38m |
Total liabilities | AU$941.54k |
Total assets | AU$7.32m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: AVE's short term assets (A$7.0M) exceed its short term liabilities (A$843.3K).
Long Term Liabilities: AVE's short term assets (A$7.0M) exceed its long term liabilities (A$98.2K).
Debt to Equity History and Analysis
Debt Level: AVE is debt free.
Reducing Debt: AVE has not had any debt for past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: AVE has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: AVE has sufficient cash runway for 1.7 years if free cash flow continues to grow at historical rates of 6.1% each year.